These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36843529)

  • 1. Biomimetic virus-like mesoporous silica nanoparticles improved cellular internalization for co-delivery of antigen and agonist to enhance Tumor immunotherapy.
    Gao Y; Zhang Y; Xia H; Ren Y; Zhang H; Huang S; Li M; Wang Y; Li H; Liu H
    Drug Deliv; 2023 Dec; 30(1):2183814. PubMed ID: 36843529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Cellular Internalization of Virus-Like Mesoporous Silica Nanoparticles Enhances Adaptive Antigen-Specific Immune Responses against Cancer.
    Phan NM; Nguyen TL; Choi Y; Mo XW; Trinh TA; Yi GR; Kim J
    ACS Appl Mater Interfaces; 2024 Sep; 16(35):45917-45928. PubMed ID: 39178210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesoporous Silica as a Versatile Platform for Cancer Immunotherapy.
    Nguyen TL; Choi Y; Kim J
    Adv Mater; 2019 Aug; 31(34):e1803953. PubMed ID: 30417454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hollow Mesoporous Silica Nanoparticles with Extra-Large Mesopores for Enhanced Cancer Vaccine.
    Lee JY; Kim MK; Nguyen TL; Kim J
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34658-34666. PubMed ID: 32662625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
    Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
    Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy.
    Lu Y; Yang Y; Gu Z; Zhang J; Song H; Xiang G; Yu C
    Biomaterials; 2018 Aug; 175():82-92. PubMed ID: 29803106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
    Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
    Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice.
    Wagner J; Gößl D; Ustyanovska N; Xiong M; Hauser D; Zhuzhgova O; Hočevar S; Taskoparan B; Poller L; Datz S; Engelke H; Daali Y; Bein T; Bourquin C
    ACS Nano; 2021 Mar; 15(3):4450-4466. PubMed ID: 33648336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold.
    Nguyen TL; Cha BG; Choi Y; Im J; Kim J
    Biomaterials; 2020 May; 239():119859. PubMed ID: 32070828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.
    Mody KT; Popat A; Mahony D; Cavallaro AS; Yu C; Mitter N
    Nanoscale; 2013 Jun; 5(12):5167-79. PubMed ID: 23657437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-Pore Mesoporous-Silica-Coated Upconversion Nanoparticles as Multifunctional Immunoadjuvants with Ultrahigh Photosensitizer and Antigen Loading Efficiency for Improved Cancer Photodynamic Immunotherapy.
    Ding B; Shao S; Yu C; Teng B; Wang M; Cheng Z; Wong KL; Ma P; Lin J
    Adv Mater; 2018 Dec; 30(52):e1802479. PubMed ID: 30387197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antigen-specific immunity by mesoporous silica nanoparticles incorporating antigen peptides.
    Goto K; Ueno T; Sakaue S
    J Biosci Bioeng; 2024 Sep; 138(3):254-260. PubMed ID: 38890051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal-Phenolic Network-Encapsulated Nanovaccine with pH and Reduction Dual Responsiveness for Enhanced Cancer Immunotherapy.
    Zhou X; Su Q; Zhao H; Cao X; Yang Y; Xue W
    Mol Pharm; 2020 Dec; 17(12):4603-4615. PubMed ID: 33175556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel biomimetic mesoporous silica nanoparticle system possessing targetability and immune synergy facilitates effective solid tumor immuno-chemotherapy.
    Zhu H; Liu Y; Yi X; Zhu C; Fu Y; Huang Z; Zhu K; Zhang W; Hou H; Sun C; Zhong C; Liu W; Li Z; Wang B; Wo J
    Biomater Adv; 2023 Jan; 144():213229. PubMed ID: 36502749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses.
    Wang N; Zuo Y; Wu S; Huang C; Zhang L; Zhu D
    Acta Pharm Sin B; 2022 Dec; 12(12):4486-4500. PubMed ID: 36561992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-like hollow mesoporous silica nanoparticles for cancer combination therapy.
    Xu D; Song X; Zhou J; Ouyang X; Li J; Deng D
    Colloids Surf B Biointerfaces; 2021 Jan; 197():111452. PubMed ID: 33189035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy.
    Yu A; Dai X; Wang Z; Chen H; Guo B; Huang L
    Biosensors (Basel); 2022 Feb; 12(2):. PubMed ID: 35200369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions.
    Godakhindi V; Tarannum M; Dam SK; Vivero-Escoto JL
    Adv Healthc Mater; 2024 Aug; 13(20):e2400323. PubMed ID: 38653190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy.
    Dong Y; Gao J; Pei M; Wang X; Zhang C; Du Y; Jiang Y
    Int J Nanomedicine; 2020; 15():2685-2697. PubMed ID: 32368049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
    Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.